Consultation
Dr. Farag reviews your neurotoxin history, evaluates your facial muscle dynamics, and discusses why Daxxify's extended duration may benefit your goals.
Daxxify in Fort Myers, FL
The Longest-Lasting Neurotoxin
Your Daxxify at a glance:
Treatment Time:10-20 minutes
Results Last:6-9 months
Downtime:None
FDA Approved:Yes
Why Frequent Touch-Ups Shouldn't Be the Norm
A Better Approach to Neurotoxins
If you've been getting Botox or Dysport, you know the cycle: treatment, three months of smooth skin, then a gradual return of lines that sends you back to the clinic. For busy professionals, parents, and travelers in Southwest Florida, scheduling quarterly injectable appointments can be inconvenient. The cost and time commitment of frequent visits adds up, and watching your results fade month after month can feel frustrating - especially when you love how you look at peak effect.
Daxxify (daxibotulinumtoxinA-lanm) changes the equation entirely. Using a novel peptide-based stabilization technology instead of traditional human serum albumin, Daxxify achieves what other neurotoxins cannot: FDA-proven duration of up to 6-9 months from a single treatment session. At RegalMed Clinic, Dr. Sherry Farag uses Daxxify to help patients enjoy extended periods of smooth, rejuvenated skin with fewer appointments, lower long-term costs, and consistent results that don't fade as quickly.
What Is Daxxify?
Peptide-Powered Neurotoxin Innovation
Daxxify (daxibotulinumtoxinA-lanm) is the newest FDA-approved injectable neurotoxin, manufactured by Revance Therapeutics. Approved by the FDA in September 2022 for the treatment of moderate to severe glabellar lines (frown lines), Daxxify represents a breakthrough in wrinkle treatment technology. It is the first and only neurotoxin that uses a proprietary peptide formulation instead of human serum albumin (HSA) or animal-derived proteins as a stabilizer.
This peptide exchange technology (Peptide Exchange Technology™) allows the botulinum toxin type A molecule to bind more efficiently and remain active at the neuromuscular junction for a significantly longer period. In clinical trials, the median duration of effect was 6 months, with some patients maintaining results for up to 9 months. The mechanism of action is the same as other neurotoxins - blocking acetylcholine release to temporarily reduce muscle activity - but the enhanced stabilization extends the therapeutic window substantially.
Treatment Timeline
Treatment Time
10-20 minutes
First Signs
3-5 days post-injection
Full Effect
14 days (peak results)
Duration
6-9 months average
Benefits of Daxxify
Extended Wrinkle-Free Results
- 01
Longest Duration
FDA-proven results lasting 6-9 months - up to twice as long as traditional options
- 02
Fewer Visits
Only 2-3 treatments per year instead of the typical 3-4 with other neurotoxins
- 03
No Animal or Human Proteins
Peptide-stabilized formula with no human serum albumin or animal-derived components
- 04
FDA Approved
Rigorously tested and approved in 2022 for moderate to severe glabellar lines
- 05
Natural Results
Smooths wrinkles while preserving your natural range of facial expression
Daxxify vs Other Neurotoxins
Compare Your Options
| Treatment | Mechanism | Time | Results | Duration | Downtime | Best For |
|---|---|---|---|---|---|---|
| Daxxify | DaxibotulinumtoxinA-lanm, peptide-stabilized | 10-20 min | 3-5 days onset | 6-9 months | None | Long-lasting wrinkle reduction |
| Botox | OnabotulinumtoxinA, HSA-stabilized | 10-20 min | 3-5 days onset | 3-4 months | None | Precise, targeted wrinkle treatment |
| Dysport | AbobotulinumtoxinA, natural diffusion | 10-20 min | 2-3 days onset | 3-4 months | None | Larger areas, faster onset |
Who Is a Good Candidate for Daxxify?
Candidacy and Considerations
Daxxify is ideal for patients who are already familiar with neurotoxin treatments and want to extend the time between appointments, as well as newcomers who value the convenience of fewer visits per year.
Ideal Candidates for Daxxify
- Adults with moderate to severe glabellar lines seeking longer-lasting results
- Current Botox or Dysport patients who want to reduce the frequency of treatments
- Busy professionals or frequent travelers who prefer fewer office visits
- Patients who prefer a product formulated without human or animal-derived proteins
- Individuals in good overall health with realistic expectations about injectable outcomes
Who Should Wait or Avoid Daxxify
- Women who are pregnant or breastfeeding
- Patients with known hypersensitivity to botulinum toxin type A or any Daxxify components
- Individuals with neuromuscular junction disorders such as myasthenia gravis or Lambert-Eaton syndrome
- Those with active skin infections at proposed injection sites
- Patients under 18 years of age
During your consultation, Dr. Farag will assess your treatment history, facial anatomy, and goals to determine if Daxxify offers the best outcomes for your situation.
What Happens During Daxxify Treatment
Preparation
The treatment area is cleansed and Dr. Farag maps precise injection sites based on your individual anatomy and muscle strength.
Injection
Using fine-gauge needles, Dr. Farag administers Daxxify into targeted muscle groups with careful attention to dosing for maximum longevity.
Post-Treatment
You receive detailed aftercare instructions and a follow-up is scheduled at two weeks to assess your results and confirm optimal placement.
Daxxify Side Effects & Safety
What to Know
Daxxify was rigorously evaluated in two pivotal Phase 3 clinical trials involving over 2,700 participants before receiving FDA approval in September 2022. Its safety profile is comparable to other FDA-approved neurotoxins.
Common Side Effects
The most commonly reported side effects include headache (occurring in approximately 6% of patients in clinical trials), mild injection site reactions such as redness, swelling, or bruising, and temporary tenderness at the treatment area. These effects are typically mild and resolve within a few days.
Less Common Side Effects
In rare cases, patients may experience eyelid drooping (ptosis), facial asymmetry, or localized muscle weakness near the injection site. These effects are temporary and resolve as the product naturally metabolizes.
Safety Advantages
Daxxify's peptide-based formulation does not contain human serum albumin or animal-derived proteins, which may be advantageous for patients with certain sensitivities. Dr. Farag reviews your full medical history and current medications before every Daxxify treatment to ensure your safety.
Daxxify Cost in Fort Myers, FL
Long-Term Value in Wrinkle Reduction
Daxxify pricing reflects its longer duration of effect. While the per-session cost may be higher than traditional neurotoxins, patients typically need only 2-3 treatments per year instead of 3-4, which can make the annual cost comparable or even lower.
Typical Pricing
Glabellar Lines: $400-$800 per treatment
Forehead + Glabellar: $500-$1,000 per treatment
Full Upper Face: $600-$1,200 per treatment
Cost Comparison (Annual)
Traditional Neurotoxin: 3-4 visits × $300-$600 = $900-$2,400/year
Daxxify: 2-3 visits × $400-$800 = $800-$2,400/year
Value Considerations
Beyond comparable costs, Daxxify saves time - fewer appointments mean less time away from work and daily life. Revance also offers a patient loyalty program called RHA Plus Rewards. Dr. Farag will provide a transparent cost estimate based on your treatment plan during your consultation.
Why Choose RegalMed Clinic for Daxxify
Fort Myers Daxxify Specialists
Early Adopter Expertise
Among the first Fort Myers providers trained and certified in Daxxify administration
Physician-Only Injections
Dr. Farag personally performs every Daxxify treatment - never delegated to staff
Full Neurotoxin Menu
Access to Botox, Dysport, and Daxxify - honest guidance on the best fit for you
Evidence-Based Approach
Treatment decisions guided by clinical research, not sales incentives
Related Services
Aesthetics
Advanced Skin Technology
Body Contouring
Daxxify FAQ
Your Questions Answered
01 How is Daxxify different from Botox?
Daxxify uses a proprietary peptide formulation instead of human serum albumin to stabilize the botulinum toxin molecule. This allows it to remain active at the neuromuscular junction significantly longer - 6-9 months vs. 3-4 months for Botox. The treatment experience is similar, but you'll need fewer appointments per year.
02 How long does Daxxify last?
In clinical trials, the median duration of Daxxify was 6 months, with many patients maintaining results for up to 9 months. This is approximately twice the duration of traditional neurotoxins like Botox and Dysport, making it the longest-lasting FDA-approved injectable wrinkle treatment available.
03 Is Daxxify FDA approved?
Yes. Daxxify (daxibotulinumtoxinA-lanm) was approved by the FDA in September 2022 for the treatment of moderate to severe glabellar lines in adults. It was evaluated in two large Phase 3 clinical trials involving over 2,700 participants before receiving approval.
04 How much does Daxxify cost?
Daxxify typically costs $400-$1,200 per treatment session depending on the areas treated. While the per-visit cost may be higher than Botox or Dysport, patients need only 2-3 treatments per year, making the annual investment comparable. Dr. Farag provides transparent pricing during your consultation.
05 Who is a good candidate for Daxxify?
Daxxify is ideal for adults with moderate to severe frown lines who want longer-lasting results with fewer office visits. It's especially popular with current Botox or Dysport patients looking to extend time between treatments. Patients with neuromuscular disorders or botulinum toxin allergies should not receive Daxxify.
Location15750 New Hampshire Ct, STE D
Fort Myers, FL, 33908
Fort Myers, FL, 33908
Phone(239) 395-2434
Schedule Your Daxxify Consultation
References
- PubMed (PMID: 36094956) - Bertucci V, et al. DaxibotulinumtoxinA-lanm (DAXXIFY) for the treatment of glabellar lines: results from SAKURA 3, a large, open-label, phase 3 safety study. Aesthet Surg J. 2022.
- PubMed (PMID: 35766820) - Solish N, et al. DaxibotulinumtoxinA-lanm for treatment of moderate to severe glabellar lines: results from two phase 3 pivotal trials (SAKURA 1 and SAKURA 2). J Am Acad Dermatol. 2022.
- PubMed (PMID: 34370886) - Carruthers J, et al. Long-duration botulinum toxin for glabellar lines: an updated review of daxibotulinumtoxinA-lanm. Dermatol Surg. 2021.
- PubMed (PMID: 36515561) - Monheit GD, et al. DaxibotulinumtoxinA-lanm: a review of its use for the treatment of glabellar lines. Clin Cosmet Investig Dermatol. 2022.
- PubMed (PMID: 37103953) - Green JB, et al. Real-world experience with daxibotulinumtoxinA-lanm for glabellar lines: patient satisfaction and duration analysis. Aesthet Surg J. 2023.